Revive A Sony Vaio P-Series With KiCad’s Background Bitmaps

You might remember that KiCad 7 came out this February, with a multitude of wonderful features. One of them was particularly exciting to see, and the KiCad newsletter even had an animated GIF to properly demo it – a feature called “Background Bitmaps”, which is the ability to add existing board images into your board editor, both front and back, and switch between them as you design the board. With it, you can draw traces, recreate the outline and place connectors over these images, giving you a way to quickly to reproduce everything on an existing PCB! I’ve seen some friends of mine use this feature, and recently, I’ve had a project come up that’s a perfect excuse for me to try it.

By [Yoggy], CC-BY-2.0
Back in 2020, I managed to get a Sony Vaio P from a flea market, for about 20€. It’s a beloved tiny laptop from 2009, now a collectors item, and we’ve covered a few hacks with it! The price was this wonderful only because it was not fit for regular flea market customers – it was in bad condition, with the original DC jack lost and replaced by some Molex-like power connector, no hard drive, and no battery in sight.

In short, something worth selling to a known tinkerer like me, but not particularly interesting otherwise. Nevertheless, about half a year later, when I fed it the desired 10.5 V from a lab PSU and gave the power button a few chances, it eventually booted up and shown me the BIOS menu on the screen! I’ve disassembled and reassembled it a few times, replaced the DC jack with an original one from a different Vaio ultrabook I happened to have parts from, and decided to try to bring it back to original condition.

Continue reading “Revive A Sony Vaio P-Series With KiCad’s Background Bitmaps”

CNC Plus Microscope Plus Game Controller Equals Awesome

What do you get if you strap a microscope onto a CNC and throw in a gaming controller? The answer, according to Reddit user [AskewedBox] is something kind of awesome: you get a microscope that can be controlled with the game controller for easier tracking of tiny creepy-crawlies.

[ASkewedBox] set up this interesting combination of devices, attaching their Adonostar AD246S microscope to the stage of a no-brand 1610 CNC bought off Amazon, then connected the CNC to a computer running Universal G-Code Sender. This great open source program takes the input from an Xbox game controller and uses it to jog the CNC.

With a bit of tweaking, the game controller can now move the microscope, so it can be used to track microbes and other small creatures as they wander around on the slide mounted below the microscope eating each other. The movement of this is surprisingly smooth: the small CNC and a well-mounted microscope means that there seems to be very little wobble or backlash as the microscope moves.

[Askewedbox] hasn’t finished yet, though: in the latest update, he adds a polarizing lens to the setup and mentions that he wants to add focus control to the system, which is controlled by a remote that comes with the microscope.

There are plenty of other things that could be added beyond that, though, such as auto pan and stitch for larger photos, auto focus stacking and perhaps even auto tracking using OpenCV to track the hideous tiny creatures that live in the microscopic realm. What would you do to make this even cooler?

2023 Halloween Hackfest: This Year’s Spooky Winners

With the zombies, ghouls, and ghosts now safely returned to their crypts until next October, it’s time to unveil this year’s winners for the 2023 Halloween Hackfest.

For this contest, sponsors DigiKey and Arduino challenged the community to come up with their best creations for what’s arguably the most hacker-friendly of holidays. Pretty much everything was fair game, from costumes to decorations. The top three winners will get $150 credit from DigiKey and some treats from Arduino — just don’t try to eat them.

Continue reading “2023 Halloween Hackfest: This Year’s Spooky Winners”

What Can You Do With Thousands Of Vintage Telephones?

Telephones. We’ve got a few around the place, and some may remember all the weird and wonderful varieties produced over the years. But, vintage phone dealers [Ron and Mary Knappen] may have a few too many. With a large 41,000 sqft property, at least three farm buildings, and no fewer than 33 semi-trailers loaded to busting with racks of phones, the retiring couple have a job sorting it all out and finding someone passionate enough to take over this once-strong business.

Technology has moved on somewhat since 1971 when they got into the retro business, and there are only so many period dramas being produced that could make a dent in a collection of a thousand steel desk phones. Nobody seems interested in taking on their business, so they are concentrating on emptying that large property in order to sell it, but the fate of the crazy number of other storage locations seems uncertain. Perhaps, other than a few museums around the world purchasing a few, this collection really is likely heading to the recyclers.

So what can we do with a vintage phone in this modern era? Here’s a primer to get you started. How about going cellular? Or maybe just add them to your existing designer collection?

Thanks to [Jeremy] and Adafruit for the tip!

3D Human Models From A Single Image

You’ve seen it in movies and shows — the hero takes a blurry still picture, and with a few keystrokes, generates a view from a different angle or sometimes even a full 3D model. Turns out, thanks to machine learning and work by several researchers, this might be possible. As you can see in the video below, using “shape-guided diffusion,” the researchers were able to take a single image of a person and recreate a plausible 3D model.

Of course, the work relies on machine learning. As you’ll see in the video, this isn’t a new idea, but previous attempts have been less than stellar. This new method uses shape prediction first, followed by an estimate of the back view appearance. The algorithm then guesses what images go between the initial photograph and the back view. However, it uses the 3D shape estimate as a guideline. Even then,  there is some post-processing to join the intermediate images together into a model.

The result looks good, although the video does point out some areas where they still fall short. For example, unusual lighting can affect the results.

This beats spinning around a person or a camera to get many images. Scanning people in 3D is a much older dream than you might expect.

Continue reading “3D Human Models From A Single Image”

How The WS2812 Is Made

[Scotty Allen] of Strange Parts is no stranger to Chinese factory tours, but this one is now our favorite. He visits the font of all WS2812s, World Semi, and takes a good look at the machines that make two million LEDs per day.

The big deal with the WS2812s, and all of the similar addressable LEDs that have followed them, is that they have a logic chip inside the LED that enables all the magic. And that means die-bonding bare-die ICs into each blinky. Watching all of the machines pick, place, glue, and melt bond wire is pretty awesome. Don’t miss the demo of the tape-and-frame. And would you believe that they test each smart LED before they kick it out the door? There’s a machine that clocks some data in and reads it back out the other side.

Do we take the addressable LED for granted today? Probably. But if you watch this video, maybe you’ll at least know what goes into making one, and the next time you’re blinking all over the place, you’ll spill a little for the epoxy-squirting machine. After all, the WS2812 is the LED that prompted us to ask, three years ago, if we could live without one.
Continue reading “How The WS2812 Is Made”

A giemsa stained blood smear from a person with beta thalassemia (Credit: Dr Graham Beards, Wikimedia Commons)

First CRISPR-Based Therapies For Sickle Cell Disease And Beta Thalassemia Approved In The UK

The gene-therapy-based treatment called Casgevy was recently approved in the UK, making it the first time that a treatment based on the CRISPR-Cas9 gene editing tool has been authorized for medical treatments. During the clinical trials, a number of patients were enrolled with either sickle cell disease (SCD) or β thalassemia, both of which are blood disorders that affect the production of healthy red blood cells. Of the 45 who enrolled for the SCD trial, 29 were evaluated in the initial 12-month efficacy assessment, with 28 of those found to be still free of the severe pain crises that characterizes SCD. For the β thalassemia trial, 42 patients were evaluated and 39 were still free of the need for red blood cell transfusions and iron chelation after the 12-month period, with the remaining three showing a marked reduction in the need for these.

Both of these blood disorders are inherited via recessive genes, meaning that in the case of SCD two abnormal copies of the β-globin (HBB) gene are required to trigger the disorder. For β thalassemia a person can be a carrier or have a variety of symptoms based on the nature of the two sets of mutated genes that involve the production of HbA (adult hemoglobin), with the severest form (β thalassemia major) requiring the patient to undergo regular transfusions. Both types of conditions have severe repercussions on overall health and longevity, with few individuals living to the age of 60.

The way that the Casgevy treatment works involves taking stem cells out of the bone marrow of the patient, after which the CRISPR-Cas9 tool is used to target the BCL11A gene and cut it out completely. This particular gene is instrumental in the switch from fetal γ globin (HBG1, HBG2) to adult β globin form. Effectively this modification causes the resulting cells to produce fetal-type hemoglobin (HbF) instead of adult HbA which would have the mutations involved in the blood disorder.

For the final step in the treatment, the modified stem cells have to be inserted back into the patient’s bone marrow, which requires another treatment to make the bone marrow susceptible to hosting the new cells. After this the patient will ideally be cured, as the stem cells produce new, HbF-producing cells that go on to create healthy hemoglobin. Although safety and costs (~US$2M per patient) considerations of such a CRISPR-Cas9 gene therapy may give pause, this has to be put against the prospect of 40-60 years of intensive symptom management.

Currently, the US FDA as well as the EU’s EMA are also looking at possibly approving the treatment, which might open the gates for similar gene-therapies.

Top image: A giemsa stained blood smear from a person with beta thalassemia. Note the lack of coloring. (Credit: Dr Graham Beards, Wikimedia Commons)